A promising therapeutic option for metabolic disorders is the activation of brown adipose tissue. The biochemist and molecular biologist Dr. Alexander Bartelt, principal investigator at the Institute for Cardiovascular Prevention at the Ludwig-Maximilians-Universität (LMU) Munich, has developed and continually advanced this concept. In his young career, he has already been able to show that the activation of brown adipose tissue can significantly reduce harmful blood fats and sugars. Moreover, he has been able to identify new intracellular mechanisms that control the function and activity of brown adipose tissue.
For his outstanding research, Dr. Alexander Bartelt is awarded this year’s Friedmund Neumann Prize. He was nominated for the prize by Prof. Dr. Jörg Heeren, Heisenberg Professor of Immunometabolism at the University Medical Center Hamburg-Eppendorf. “Alexander Bartelt’s excellent achievements are based on scientific curiosity, which, together with his brilliant mind and the application of innovative technologies, has led to pathbreaking works in the field of metabolism research. His widely cited studies have not only contributed to a better biological understanding of brown adipose tissue; they have also shown the therapeutic relevance of this fascinating tissue for treating metabolic disorders such as type 2 diabetes,” says Heeren.
September 26, 2018, 5:30–7 p.m.
Leibniz Hall at the Berlin-Brandenburg Academy of Sciences and Humanities
Markgrafenstr. 38 | 10117 Berlin
Registration is possible until September 19 at www.scheringstiftung.de/Preisverleihung2018.
September 27, 2018
Alexander Bartelt
OSZ Lise-Meitner-Schule, Berlin-Neukölln (not open to the public)
Unter den Linden 32-34
10117 Berlin
Telefon: +49.30.20 62 29 62
Email: info@scheringstiftung.de
Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance